Early adopters cite promise of pattern-scan photocoagulation

The use of a pattern-scan laser system (Pascal Photocoagulator, OptiMedica Corp.) to treat diabetic retinopathy and other retinal disorders is showing substantial advantages over conventional single-burn techniques, according to a growing body of clinical experience. Early adopters say key attributes include better targeting of photocoagulation burns to fit specific retinal conditions, less patient discomfort due to lower applied laser power, and improved overall clinical efficiency because the number and duration of treatments are sharply reduced.